• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型人类溶血磷脂酸G蛋白偶联受体EDG7的分子克隆与特性分析

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.

作者信息

Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K

机构信息

Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

出版信息

J Biol Chem. 1999 Sep 24;274(39):27776-85. doi: 10.1074/jbc.274.39.27776.

DOI:10.1074/jbc.274.39.27776
PMID:10488122
Abstract

Lysophosphatidic acid (LPA), together with sphingosine 1-phosphate, is a bioactive lipid mediator that acts on G-protein-coupled receptors to evoke multiple cellular responses, including Ca(2+) mobilization, modulation of adenylyl cyclase, and mitogen-activated protein (MAP) kinase activation. In this study, we isolated a human cDNA encoding a novel G-protein-coupled receptor, designated EDG7, and characterized it as a cellular receptor for LPA. The amino acid sequence of the EDG7 protein is 53.7 and 48.8% identical to those of the human functional LPA receptors EDG2 and EDG4, respectively, previously identified. LPA (oleoyl) but not other lysophospholipids induced an increase in the Ca(2+) of EDG7-overexpressing Sf9 cells. Other LPA receptors, EDG4 but not EDG2, transduced the Ca(2+) response by LPA when expressed in Sf9 cells. LPAs with an unsaturated fatty acid but not with a saturated fatty acid induced an increase in the Ca(2+) of EDG7-expressing Sf9 cells, whereas LPAs with both saturated and unsaturated fatty acids elicited a Ca(2+) response in Sf9 cells expressing EDG4. In EDG7- or EDG4-expressing Sf9 cells, LPA stimulated forskolin-induced increase in intracellular cAMP levels, which was not observed in EDG2-expressing cells. In PC12 cells, EDG4 but not EDG2 or EDG7 mediated the activation of MAP kinase by LPA. Neither the EDG7- nor EDG4-transduced Ca(2+) response or cAMP accumulation was inhibited by pertussis toxin. In conclusion, the present study demonstrates that EDG7, a new member of the EDG family of G-protein-coupled receptors, is a specific LPA receptor that shows distinct properties from known cloned LPA receptors in ligand specificities, Ca(2+) response, modulation of adenylyl cyclase, and MAP kinase activation.

摘要

溶血磷脂酸(LPA)与1-磷酸鞘氨醇一样,是一种生物活性脂质介质,作用于G蛋白偶联受体,引发多种细胞反应,包括钙离子动员、腺苷酸环化酶调节和丝裂原活化蛋白(MAP)激酶激活。在本研究中,我们分离出一种编码新型G蛋白偶联受体的人类cDNA,命名为EDG7,并将其鉴定为LPA的细胞受体。EDG7蛋白的氨基酸序列与先前鉴定的人类功能性LPA受体EDG2和EDG4的氨基酸序列分别具有53.7%和48.8%的同一性。LPA(油酰基)而非其他溶血磷脂能诱导过表达EDG7的Sf9细胞内钙离子浓度升高。其他LPA受体,即EDG4而非EDG2,在Sf9细胞中表达时能转导LPA引起的钙离子反应。含有不饱和脂肪酸而非饱和脂肪酸的LPA能诱导表达EDG7的Sf9细胞内钙离子浓度升高,而同时含有饱和脂肪酸和不饱和脂肪酸的LPA能在表达EDG4的Sf9细胞中引发钙离子反应。在表达EDG7或EDG4的Sf9细胞中,LPA刺激了福斯高林诱导的细胞内cAMP水平升高,而在表达EDG2的细胞中未观察到这种现象。在PC12细胞中,EDG4而非EDG2或EDG7介导了LPA对MAP激酶的激活。百日咳毒素既不抑制EDG7也不抑制EDG4转导的钙离子反应或cAMP积累。总之,本研究表明,G蛋白偶联受体EDG家族的新成员EDG7是一种特异性LPA受体,在配体特异性、钙离子反应、腺苷酸环化酶调节和MAP激酶激活方面表现出与已知克隆的LPA受体不同的特性。

相似文献

1
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.一种新型人类溶血磷脂酸G蛋白偶联受体EDG7的分子克隆与特性分析
J Biol Chem. 1999 Sep 24;274(39):27776-85. doi: 10.1074/jbc.274.39.27776.
2
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.EDG家族的溶血磷脂酸(LPA)受体可被不同种类的LPA差异性激活。克隆的LPA受体的构效关系。
FEBS Lett. 2000 Jul 28;478(1-2):159-65. doi: 10.1016/s0014-5793(00)01827-5.
3
Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.溶血磷脂酸(LPA)受体被生物体液差异性激活:LPA结合蛋白在LPA受体激活中的可能作用。
FEBS Lett. 2002 Jul 17;523(1-3):187-92. doi: 10.1016/s0014-5793(02)02976-9.
4
Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.重组人G蛋白偶联溶血磷脂酸受体介导细胞内钙动员。
Mol Pharmacol. 1998 Nov;54(5):881-8. doi: 10.1124/mol.54.5.881.
5
Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.一种新型人类溶血磷脂酸G蛋白偶联受体亚型的特性分析。
J Biol Chem. 1998 Apr 3;273(14):7906-10. doi: 10.1074/jbc.273.14.7906.
6
Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid.鉴定一种EDG7变体HOFNH30,一种溶血磷脂酸的G蛋白偶联受体。
Biochem Biophys Res Commun. 2000 Jul 14;273(3):805-10. doi: 10.1006/bbrc.2000.2943.
7
Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.溶血磷脂酰乙醇胺在 MDA-MB-231 乳腺癌细胞中利用 LPA(1)和 CD97。
Cell Signal. 2013 Nov;25(11):2147-54. doi: 10.1016/j.cellsig.2013.07.001. Epub 2013 Jul 6.
8
A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.单个氨基酸决定了鞘氨醇-1-磷酸(S1P1,即EDG1)和溶血磷脂酸-1(LPA1,即EDG2)磷脂生长因子受体的溶血磷脂特异性。
J Biol Chem. 2001 Dec 28;276(52):49213-20. doi: 10.1074/jbc.M107301200. Epub 2001 Oct 16.
9
Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).溶血磷脂酸受体lpa(2)(Edg4)和lpa(1)/lpa(2)(Edg2/Edg4)基因敲除小鼠的特征:信号缺陷但无明显可归因于lpa(2)的表型异常。
Mol Cell Biol. 2002 Oct;22(19):6921-9. doi: 10.1128/MCB.22.19.6921-6929.2002.
10
Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid.人类Edg2蛋白的分子克隆及其作为溶血磷脂酸功能性细胞受体的鉴定。
Biochem Biophys Res Commun. 1997 Feb 24;231(3):619-22. doi: 10.1006/bbrc.1997.6150.

引用本文的文献

1
Lysophosphatidic Acid Receptor 3 (LPA3): Signaling and Phosphorylation Sites.溶血磷脂酸受体 3(LPA3):信号转导和磷酸化位点。
Int J Mol Sci. 2024 Jun 12;25(12):6491. doi: 10.3390/ijms25126491.
2
The interaction of platelet-related factors with tumor cells promotes tumor metastasis.血小板相关因子与肿瘤细胞的相互作用促进了肿瘤转移。
J Transl Med. 2024 Apr 18;22(1):371. doi: 10.1186/s12967-024-05126-6.
3
Structural basis for lysophosphatidylserine recognition by GPR34.GPR34 识别溶血磷脂酰丝氨酸的结构基础。
Nat Commun. 2024 Feb 7;15(1):902. doi: 10.1038/s41467-024-45046-z.
4
Synthesis and Biological Evaluation of Lysophosphatidic Acid Analogues Using Conformational Restriction and Bioisosteric Replacement Strategies.使用构象限制和生物电子等排体替换策略合成溶血磷脂酸类似物并进行生物学评价。
ACS Omega. 2023 Dec 11;8(51):49278-49288. doi: 10.1021/acsomega.3c07668. eCollection 2023 Dec 26.
5
Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.溶血磷脂酸在巨噬细胞和炎症性疾病中的新作用。
Int J Mol Sci. 2023 Aug 7;24(15):12524. doi: 10.3390/ijms241512524.
6
In Vitro Animal Model for Estimating the Time since Death with Attention to Early Postmortem Stage.用于估计死亡时间并关注死后早期阶段的体外动物模型。
Metabolites. 2022 Dec 23;13(1):26. doi: 10.3390/metabo13010026.
7
LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells.LPAR1 和异常表达的 LPAR3 分别促进恶性外周神经鞘瘤细胞的迁移和增殖。
Glia. 2023 Mar;71(3):742-757. doi: 10.1002/glia.24308. Epub 2022 Nov 23.
8
Effects of lysophosphatidic acid on sling and clasp fibers of the human lower esophageal sphincter.溶血磷脂酸对人下食管括约肌吊带和扣状纤维的影响。
Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jul 29;30(3):404-409. doi: 10.5606/tgkdc.dergisi.2022.22084. eCollection 2022 Jul.
9
LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network.LPAR2介导的作用通过MAPK/NF-κB信号通路促进人肾细胞癌,以调节细胞因子网络。
J Cancer Res Clin Oncol. 2023 May;149(5):2041-2055. doi: 10.1007/s00432-022-04197-6. Epub 2022 Jul 20.
10
Lysophosphatidic acid supports the development of vitrified ovarian follicles by decreasing the incidence of cell death: An experimental study.溶血磷脂酸通过降低细胞死亡发生率来支持玻璃化冷冻卵巢卵泡的发育:一项实验研究。
Int J Reprod Biomed. 2022 May 23;20(4):273-288. doi: 10.18502/ijrm.v20i4.10899. eCollection 2022 Apr.